These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37711809)

  • 21. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
    Chen J; Zhou R
    PeerJ; 2021; 9():e10628. PubMed ID: 33520448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
    Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
    Front Surg; 2022; 9():836080. PubMed ID: 35392063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
    Lin Z; Xu Q; Miao D; Yu F
    Front Oncol; 2021; 11():644416. PubMed ID: 33828988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer.
    Wan S; Zhou T; Che R; Li Y; Peng J; Wu Y; Gu S; Cheng J; Hua X
    J Ovarian Res; 2023 Jan; 16(1):1. PubMed ID: 36597144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma.
    Li Y; Li Y; Zhang X; Duan X; Feng H; Yu Z; Gao Y
    Front Oncol; 2022; 12():986827. PubMed ID: 36267972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploration of a noninvasive radiomics classifier for breast cancer tumor microenvironment categorization and prognostic outcome prediction.
    Han X; Gong Z; Guo Y; Tang W; Wei X
    Eur J Radiol; 2024 Jun; 175():111441. PubMed ID: 38537607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying Dendritic Cell-Related Genes Through a Co-Expression Network to Construct a 12-Gene Risk-Scoring Model for Predicting Hepatocellular Carcinoma Prognosis.
    Huang C; Jiang X; Huang Y; Zhao L; Li P; Liu F
    Front Mol Biosci; 2021; 8():636991. PubMed ID: 34109210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma.
    Li G; Xu S; Yang S; Wu C; Zhang L; Wang H
    Front Genet; 2022; 13():1029576. PubMed ID: 36568382
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification and validation in a novel quantification system of the glutamine metabolism patterns for the prediction of prognosis and therapy response in hepatocellular carcinoma.
    Jin S; Cao J; Kong LB
    J Gastrointest Oncol; 2022 Oct; 13(5):2505-2521. PubMed ID: 36388696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging-based radiomics was used to evaluate the level of prognosis-related immune cell infiltration in breast cancer tumor microenvironment.
    Qian H; Ren X; Xu M; Fang Z; Zhang R; Bu Y; Zhou C
    BMC Med Imaging; 2024 Feb; 24(1):31. PubMed ID: 38308230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes.
    Yan J; Cao J; Chen Z
    BMC Cancer; 2021 Feb; 21(1):175. PubMed ID: 33602168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring potential targets of Actinidia chinensis Planch root against hepatocellular carcinoma based on network pharmacology and molecular docking and development and verification of immune-associated prognosis features for hepatocellular carcinoma.
    Qu M; Han T; Chen X; Sun Q; Li Q; Zhao M
    J Gastrointest Oncol; 2022 Jun; 13(3):1289-1307. PubMed ID: 35837167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
    Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
    Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
    [No Abstract]   [Full Text] [Related]  

  • 37. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
    Kim J; Choi SJ; Lee SH; Lee HY; Park H
    AJR Am J Roentgenol; 2018 Nov; 211(5):1026-1034. PubMed ID: 30240304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
    Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X
    Front Immunol; 2022; 13():1076045. PubMed ID: 36591279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma.
    Yang Z; Li X; Pan C; Li Y; Lin L; Jin Y; Zheng J; Yu Z
    BMC Cancer; 2022 Dec; 22(1):1344. PubMed ID: 36550445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed tomography radiomics signature via machine learning predicts
    Li Q; Long X; Lin Y; Liang R; Li Y; Ge L
    J Gastrointest Oncol; 2023 Jun; 14(3):1462-1477. PubMed ID: 37435222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.